James McCullough | executive |
Thomas McLain | executive |
Oliver Sterling | executive |
Daniel Arias | analyst |
Jens Lindqvist | analyst |
Fergus Fleming | executive |
Randy Baron | analyst |
Chaitanya Gollakota | analyst |
Good morning, and welcome to the Renalytix conference call to review second quarter and first half fiscal year 2023 financial results. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of CapComm Partners for a few introductory comments.
Thank you, Michelle. Good morning, and welcome to the Renalytix conference call to review second quarter and first half fiscal year 2023 financial results.